Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations

İpek Özcan, Erkan Azizoğlu, Taner Şenyiğit, Mine Özyazıcı, Özgen ÖzerEge University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, TurkeyAbstract: The objective of this study was to prepare a suitable formulation for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Özcan İ, Azizoğlu E, Şenyiğit T, Özyazıcı M, Özer Ö
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/4a1c4cdf070a489ea4ec5b4a07660cda
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4a1c4cdf070a489ea4ec5b4a07660cda
record_format dspace
spelling oai:doaj.org-article:4a1c4cdf070a489ea4ec5b4a07660cda2021-12-02T07:45:07ZEnhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations1176-91141178-2013https://doaj.org/article/4a1c4cdf070a489ea4ec5b4a07660cda2013-01-01T00:00:00Zhttp://www.dovepress.com/enhanced-dermal-delivery-of-diflucortolone-valerate-using-lecithinchit-a12082https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013İpek Özcan, Erkan Azizoğlu, Taner Şenyiğit, Mine Özyazıcı, Özgen ÖzerEge University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, TurkeyAbstract: The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that would maintain the localization in skin layers without any penetration and to optimize efficiency of DFV. Drug-loaded lecithin/chitosan nanoparticles with high entrapment efficiency (86.8%), were successfully prepared by ionic interaction technique. Sustained release of DFV was achieved without any initial burst release. Nanoparticles were also incorporated into chitosan gel at different ratios for preparing a more suitable formulation for topical drug delivery with adequate viscosity. In ex-vivo permeation studies, nanoparticles increased the accumulation of DFV especially in the stratum corneum + epidermis of rat skin without any significant permeation. Retention of DFV from nanoparticle in chitosan gel formulation (0.01%) was twofold higher than commercial cream, although it contained ten times less DFV. Nanoparticles in gel formulations produced significantly higher edema inhibition in rats compared with commercial cream in in-vivo studies. Skin blanching assay using a chromameter showed vasoconstriction similar to that of the commercial product. There were no barrier function changes upon application of nanoparticles. In-vitro and in-vivo results demonstrated that lecithin/chitosan nanoparticles in chitosan gel may be a promising carrier for dermal delivery of DFV in various skin disorders.Keywords: skin permeation, anti-inflammatory activity, skin blanching, TEWLÖzcan İAzizoğlu EŞenyiğit TÖzyazıcı MÖzer ÖDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2013, Iss default, Pp 461-475 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Özcan İ
Azizoğlu E
Şenyiğit T
Özyazıcı M
Özer Ö
Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
description İpek Özcan, Erkan Azizoğlu, Taner Şenyiğit, Mine Özyazıcı, Özgen ÖzerEge University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Bornova, Izmir, TurkeyAbstract: The objective of this study was to prepare a suitable formulation for dermal delivery of diflucortolone valerate (DFV) that would maintain the localization in skin layers without any penetration and to optimize efficiency of DFV. Drug-loaded lecithin/chitosan nanoparticles with high entrapment efficiency (86.8%), were successfully prepared by ionic interaction technique. Sustained release of DFV was achieved without any initial burst release. Nanoparticles were also incorporated into chitosan gel at different ratios for preparing a more suitable formulation for topical drug delivery with adequate viscosity. In ex-vivo permeation studies, nanoparticles increased the accumulation of DFV especially in the stratum corneum + epidermis of rat skin without any significant permeation. Retention of DFV from nanoparticle in chitosan gel formulation (0.01%) was twofold higher than commercial cream, although it contained ten times less DFV. Nanoparticles in gel formulations produced significantly higher edema inhibition in rats compared with commercial cream in in-vivo studies. Skin blanching assay using a chromameter showed vasoconstriction similar to that of the commercial product. There were no barrier function changes upon application of nanoparticles. In-vitro and in-vivo results demonstrated that lecithin/chitosan nanoparticles in chitosan gel may be a promising carrier for dermal delivery of DFV in various skin disorders.Keywords: skin permeation, anti-inflammatory activity, skin blanching, TEWL
format article
author Özcan İ
Azizoğlu E
Şenyiğit T
Özyazıcı M
Özer Ö
author_facet Özcan İ
Azizoğlu E
Şenyiğit T
Özyazıcı M
Özer Ö
author_sort Özcan İ
title Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_short Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_full Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_fullStr Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_full_unstemmed Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
title_sort enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/4a1c4cdf070a489ea4ec5b4a07660cda
work_keys_str_mv AT ampoumlzcani enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT azizoglue enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT senyigitt enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT ampoumlzyazıcım enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
AT ampoumlzerampouml enhanceddermaldeliveryofdiflucortolonevalerateusinglecithinchitosannanoparticlesinvitroandinvivoevaluations
_version_ 1718399221289189376